Quality of life of palliative chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction treated with irinotecan combined with 5-fluorouracil and folinic acid: results of a randomised phase III trial

Curran, Desmond; Pozzo, Carmelo; Zaluski, Jerzy; Dank, Magdalena; Barone, Carlo; Valvere, Vahur; YALÇIN, ŞUAYİB; Peschel, Christian; Wenczl, Miklos; GÖKER, ERDEM; Bugat, Roland

doi:10.1007/s11136-009-9493-z

Quality of life of palliative chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction treated with irinotecan combined with 5-fluorouracil and folinic acid: results of a randomised phase III trial

Curran D., Pozzo C., Zaluski J., Dank M., Barone C., Valvere V., ...Daha Fazla

QUALITY OF LIFE RESEARCH, cilt.18, sa.7, ss.853-861, 2009 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 18 Sayı: 7
Basım Tarihi: 2009
Doi Numarası: 10.1007/s11136-009-9493-z
Dergi Adı: QUALITY OF LIFE RESEARCH
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.853-861
Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
Hacettepe Üniversitesi Adresli: Evet

Özet

The quality of life (QL) of advanced gastric cancer patients receiving irinotecan, folinic acid and 5-fluorouracil (5-FU) (IF arm) or cisplatin with 5-FU (CF arm) is presented.